Download PDF
Am J Perinatol 2021; 38(09): 952-959
DOI: 10.1055/s-0039-1701026
Original Article

Morbidity Outcomes of Very Low Birth Weight Neonates Receiving Parenteral Nutrition with Fish Oil Enriched Lipid Emulsion or Lipid Emulsion with Soybean Oil: An Observational Study

José Uberos
1   Neonatal Intensive Care Unit, San Cecilio Clinical Hospital, Granada, Spain
2   Medicine Faculty. Granada, Spain
,
Sara Jiménez-Montilla
1   Neonatal Intensive Care Unit, San Cecilio Clinical Hospital, Granada, Spain
,
Manuel Molina-Oya
1   Neonatal Intensive Care Unit, San Cecilio Clinical Hospital, Granada, Spain
,
Pelayo Nieto-Gómez
3   Pharmacy Service, San Cecilio Clinical Hospital, Granada, Spain
,
Isabel Cubero Millan
1   Neonatal Intensive Care Unit, San Cecilio Clinical Hospital, Granada, Spain
› Author Affiliations Funding None.
› Further Information
    Permissions and Reprints

Abstract

Intralipid (Fresenius Kabi) was the most commonly used lipid emulsion in parenteral nutrition (PN), with a 100% soybean oil composition, a low vitamin E content, and a ω-6: ω-3 ratio of 7:1. A recent alternative formulation is SMOFlipid (Fresenius Kabi), with a ω-6: ω-3 ratio of 5:2 and higher vitamin E content. A retrospective observational study was conducted to determine neonatal morbidity in very low birth weight (VLBW) premature infants during two periods: P1, when PN was based exclusively on Intralipid, and P2, when only SMOFlipid was supplied. In total, 170 VLBW neonates were analyzed, of whom 103 received PN for more than 6 days, 56 during P1, and 47 during P2. In both periods, the antenatal and neonatal characteristics of the cohort were comparable. In this analysis, the prevalence of associated comorbidities was determined. During P2, there were fewer cases of moderate to severe bronchopulmonary dysplasia (BPD) and of cholestasis, but more cases of late sepsis, mainly Staphylococcus epidermidis. No changes in the prevalence of other neonatal comorbidities were observed. We believe that the SMOFlipid used in PN could discreetly improve the prevalence of cholestasis or BPD.

Keywords

parenteral nutrition - neonatal morbidity - long-chain polyunsaturated fatty acids - bronchopulmonar dysplasia - late onset sepsis - necrotizing enterocolitis - intraventricular hemorrhage - persistent ductus arteriosus

Authors' Contributions

All authors have read and approved the final manuscript. J.U. designed the research study and drafted the manuscript. S.J.M., M.M.O., P.N.G., and E.N.L. coordinated and prepared the database and analyzed the data.


Ethical Approval

The protocol was approved by the ethics committee of the hospital and all current regulations regarding data confidentiality were complied with.




Publication History

Received: 12 August 2019

Accepted: 17 December 2019

Article published online:
27 January 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Dinerstein A, Nieto RM, Solana CL, Perez GP, Otheguy LE, Larguia AM. Early and aggressive nutritional strategy (parenteral and enteral) decreases postnatal growth failure in very low birth weight infants. J Perinatol 2006; 26 (07) 436-442
    CrossrefPubMedGoogle Scholar
  • 2 Crawford M. Placental delivery of arachidonic and docosahexaenoic acids: implications for the lipid nutrition of preterm infants. Am J Clin Nutr 2000; 71 (1, Suppl) 275S-284S
    CrossrefPubMedGoogle Scholar
  • 3 Driscoll DF, Bistrian BR, Demmelmair H, Koletzko B. Pharmaceutical and clinical aspects of parenteral lipid emulsions in neonatology. Clin Nutr 2008; 27 (04) 497-503
    CrossrefPubMedGoogle Scholar
  • 4 Buoite Stella A, Gortan Cappellari G, Barazzoni R, Zanetti M. Update on the impact of omega 3 fatty acids on inflammation, insulin resistance and sarcopenia: a review. Int J Mol Sci 2018; 19 (01) E218
    CrossrefPubMedGoogle Scholar
  • 5 Calder PC. Omega-3 fatty acids and inflammatory processes. Nutrients 2010; 2 (03) 355-374
    CrossrefPubMedGoogle Scholar
  • 6 Vlaardingerbroek H, Veldhorst MA, Spronk S, van den Akker CH, van Goudoever JB. Parenteral lipid administration to very-low-birth-weight infants--early introduction of lipids and use of new lipid emulsions: a systematic review and meta-analysis. Am J Clin Nutr 2012; 96 (02) 255-268
    CrossrefPubMedGoogle Scholar
  • 7 Simmer K, Rao SC. Early introduction of lipids to parenterally-fed preterm infants. Cochrane Database Syst Rev 2005; (02) CD005256
    PubMedGoogle Scholar
  • 8 Riskin A, Hartman C, Shamir R. Parenteral nutrition in very low birth weight preterm infants. Isr Med Assoc J 2015; 17 (05) 310-315
    PubMedGoogle Scholar
  • 9 Skouroliakou M, Konstantinou D, Agakidis C. et al. Cholestasis, bronchopulmonary dysplasia, and lipid profile in preterm infants receiving MCT/ω-3-PUFA-containing or soybean-based lipid emulsions. Nutr Clin Pract 2012; 27 (06) 817-824
    CrossrefPubMedGoogle Scholar
  • 10 Biniwale MA, Ehrenkranz RA. The role of nutrition in the prevention and management of bronchopulmonary dysplasia. Semin Perinatol 2006; 30 (04) 200-208
    CrossrefPubMedGoogle Scholar
  • 11 Koletzko B, Goulet O, Hunt J, Krohn K, Shamir R. Parenteral Nutrition Guidelines Working Group; European Society for Clinical Nutrition and Metabolism; European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN); European Society of Paediatric Research (ESPR). 1. Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), Supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr 2005; 41 (Suppl. 02) S1-S87
    CrossrefPubMedGoogle Scholar
  • 12 Manzanares W, Langlois PL, Dhaliwal R, Lemieux M, Heyland DK. Intravenous fish oil lipid emulsions in critically ill patients: an updated systematic review and meta-analysis. Crit Care 2015; 19: 167
    CrossrefPubMedGoogle Scholar
  • 13 Najm S, Löfqvist C, Hellgren G. et al. Effects of a lipid emulsion containing fish oil on polyunsaturated fatty acid profiles, growth and morbidities in extremely premature infants: a randomized controlled trial. Clin Nutr ESPEN 2017; 20: 17-23
    CrossrefPubMedGoogle Scholar
  • 14 Martin CR, Dasilva DA, Cluette-Brown JE. et al. Decreased postnatal docosahexaenoic and arachidonic acid blood levels in premature infants are associated with neonatal morbidities. J Pediatr 2011; 159 (05) 743-749
    CrossrefPubMedGoogle Scholar
  • 15 Zhang P, Lavoie PM, Lacaze-Masmonteil T, Rhainds M, Marc I. Omega-3 long-chain polyunsaturated fatty acids for extremely preterm infants: a systematic review. Pediatrics 2014; 134 (01) 120-134
    CrossrefPubMedGoogle Scholar
  • 16 Pawlik D, Lauterbach R, Walczak M, Hurkała J, Sherman MP. Fish-oil fat emulsion supplementation reduces the risk of retinopathy in very low birth weight infants: a prospective, randomized study. J Parenter Enteral Nutr 2014; 38 (06) 711-716
    CrossrefPubMedGoogle Scholar
  • 17 Narbona López E, Uberos Fernández J, Armadá Maresca MI, Couce Pico ML, Rodríguez Martínez G, Saenz de Pipaon M. [Nutrition and metabolism group of the spanish neonatology society: recommendations and evidence for dietary supplementation with probiotics in very low birth weight infants]. An Pediatr (Barc) 2014; 81 (06) 397.e1-397.e8
    CrossrefPubMedGoogle Scholar
  • 18 Fenton TR, Sauve RS. Using the LMS method to calculate z-scores for the Fenton preterm infant growth chart. Eur J Clin Nutr 2007; 61 (12) 1380-1385
    CrossrefPubMedGoogle Scholar
  • 19 Ehrenkranz RA, Walsh MC, Vohr BR. et al; National Institutes of Child Health and Human Development Neonatal Research Network. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 2005; 116 (06) 1353-1360
    CrossrefPubMedGoogle Scholar
  • 20 Jobe AH, Bancalari E. Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001; 163 (07) 1723-1729
    CrossrefPubMedGoogle Scholar
  • 21 International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol 2005; 123 (07) 991-999
    CrossrefPubMedGoogle Scholar
  • 22 Lad EM, Hernandez-Boussard T, Morton JM, Moshfeghi DM. Incidence of retinopathy of prematurity in the United States: 1997 through 2005. Am J Ophthalmol 2009; 148 (03) 451-458
    CrossrefPubMedGoogle Scholar
  • 23 Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr 1978; 92 (04) 529-534
    CrossrefPubMedGoogle Scholar
  • 24 Caplan MS, Jilling T. New concepts in necrotizing enterocolitis. Curr Opin Pediatr 2001; 13 (02) 111-115
    CrossrefPubMedGoogle Scholar
  • 25 von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007; 147 (08) 573-577
    Google Scholar
  • 26 Garcia-Serrano JL, Uberos Fernández J, Anaya-Alaminos R. et al. “Oxygen with love” and diode laser treatment decreases comorbidity and avoidable blindness due to retinopathy of prematurity: results achieved in the past 12 years. Pediatr Neonatol 2013; 54 (06) 397-401
    CrossrefPubMedGoogle Scholar
  • 27 Agostoni C, Buonocore G, Carnielli VP. et al; ESPGHAN Committee on Nutrition. Enteral nutrient supply for preterm infants: commentary from the European Society of Paediatric Gastroenterology, Hepatology and Nutrition Committee on Nutrition. J Pediatr Gastroenterol Nutr 2010; 50 (01) 85-91
    CrossrefPubMedGoogle Scholar
  • 28 de Meijer VE, Gura KM, Le HD, Meisel JA, Puder M. Fish oil-based lipid emulsions prevent and reverse parenteral nutrition-associated liver disease: the Boston experience. JPEN J Parenter Enteral Nutr 2009; 33 (05) 541-547
    CrossrefPubMedGoogle Scholar
  • 29 Kapoor V, Glover R, Malviya MN. Alternative lipid emulsions versus pure soy oil based lipid emulsions for parenterally fed preterm infants. Cochrane Database Syst Rev 2015; (12) CD009172
    PubMedGoogle Scholar
  • 30 Hsiao CC, Lin HC, Chang YJ. et al. Intravenous fish oil containing lipid emulsion attenuates inflammatory cytokines and the development of bronchopulmonary dysplasia in very premature infants: a double-blind, randomized controlled trial. Clin Nutr 2019; 38 (03) 1045-1052
    CrossrefPubMedGoogle Scholar
  • 31 Freeman J, Goldmann DA, Smith NE, Sidebottom DG, Epstein MF, Platt R. Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med 1990; 323 (05) 301-308
    CrossrefPubMedGoogle Scholar
  • 32 Vlaardingerbroek H, Roelants JA, Rook D. et al. Adaptive regulation of amino acid metabolism on early parenteral lipid and high-dose amino acid administration in VLBW infants - a randomized, controlled trial. Clin Nutr 2014; 33 (06) 982-990
    CrossrefPubMedGoogle Scholar
  • 33 Savini S, D'Ascenzo R, Biagetti C. et al. The effect of 5 intravenous lipid emulsions on plasma phytosterols in preterm infants receiving parenteral nutrition: a randomized clinical trial. Am J Clin Nutr 2013; 98 (02) 312-318
    CrossrefPubMedGoogle Scholar
  • 34 D'Ascenzo R, Savini S, Biagetti C. et al. Higher docosahexaenoic acid, lower arachidonic acid and reduced lipid tolerance with high doses of a lipid emulsion containing 15% fish oil: a randomized clinical trial. Clin Nutr 2014; 33 (06) 1002-1009
    CrossrefPubMedGoogle Scholar
  • 35 Beken S, Dilli D, Fettah ND, Kabataş EU, Zenciroğlu A, Okumuş N. The influence of fish-oil lipid emulsions on retinopathy of prematurity in very low birth weight infants: a randomized controlled trial. Early Hum Dev 2014; 90 (01) 27-31
    CrossrefPubMedGoogle Scholar